On 5 August 2016
GlaxoSmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the Company on 5 August 2016 to consider and take on record the unaudited Financial Results for the quarter ended June 30, 2016 (Q1) with Limited Review by Auditors.Powered by Capital Market - Live News
